<DOC>
	<DOCNO>NCT00905801</DOCNO>
	<brief_summary>This experimental study feasibility efficacy CT perfusion ( CTP ) imaging ( CT blood flow measurement ) subject non-small cell lung cancer .</brief_summary>
	<brief_title>Computed Tomography ( CT ) Perfusion Imaging Lung Cancer</brief_title>
	<detailed_description>Drug/Device Information 1 ) Contrast 30 cc bolus low osmolar , iodinate CT contrast agent , FDA approve used clinical CT Imaging procedure . 2 ) Scanner The 64 row-multidetector row CT unit ( LightSpeed VCT , GE Healthcare , Milwaukee , WI ) FDA approve clinical CT image Research Design Methods 1 ) Primary Endpoint 1 . Diagnostic yield tumor perfusion measurement use contrast assist computed tomography technique . 2 ) Secondary Endpoints 1 . Reproducibility tumor blood flow estimate derive CT. 2 . Assessment association tumor vascularity responses two cycle chemotherapy subsequent best tumor response accord standard anatomic response evaluation criterion ( RECIST ) . 3 . Predictive value tumor blood flow patient survival , compare predictive power tumor size determination .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patient stage nonsmall cell lung cancer ( NSCLC ) undergo image CT chest intravenous contrast standard care . Other image test perform clinically indicate . Patient receiving , plan receive , receive systemic therapy ( chemotherapy and/or novel agent ) treatment without radiotherapy . Patients receive adjuvant postoperative treatment neoadjuvant treatment allow . Histologically cytologically proven NSCLC . At least one measurable primary intrathoracic/supraclavicular lesion â‰¥ 1 cm , accord Response Evaluation Criteria Solid Tumors ( RECIST ) ; lesion either proven malignant biopsy consider malignant base evolution previous image study . A scan within 36 month prior registration use baseline scan . Age 18 year old ability provide inform consent . Subjects must use medically appropriate contraception sexually active ; woman childbearing potential must pregnant breastfeeding Subjects must normal renal function participate . Standard laboratory test evaluate renal function perform prior administer IV contrast available standard care . Renal impairment define glomerular filtration rate le 60 ml/min/1.73 m2 BSA , derive patient ' serum creatinine concentration . Subjects reproductive potential , sexually active unwilling and/or unable use medically appropriate contraception , woman pregnant breastfeeding ; Established allergy iodine contain contrast medium</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Non small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>CTP</keyword>
	<keyword>Perfusion</keyword>
	<keyword>Imaging</keyword>
</DOC>